Evidence that inositol 1,4,5-trisphosphate 3-kinase and inositol 1,3,4,5-tetrakisphosphate are negative regulators of platelet function.

inositol 1,3,4,5-tetrakisphosphate inositol 1,4,5-trisphosphate 3-kinase phosphatidylinositol 3,4,5-trisphosphate phosphoinositide 3-kinase platelet activation

Journal

Research and practice in thrombosis and haemostasis
ISSN: 2475-0379
Titre abrégé: Res Pract Thromb Haemost
Pays: United States
ID NLM: 101703775

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 01 08 2023
revised: 21 12 2023
accepted: 03 01 2024
medline: 26 2 2024
pubmed: 26 2 2024
entrez: 26 2 2024
Statut: epublish

Résumé

Inositol 1,3,4,5-tetrakisphosphate (IP To better elucidate a function for IP Human platelets were utilized in whole blood for thrombus formation, in platelet-rich plasma and washed suspensions for aggregation, and for Ca GNF362-enhanced platelet aggregation stimulated by low concentrations of ADP, collagen, thrombin, U46619, and thrombus formation in collagen-coated capillaries. GNF362 induced a transient elevation of Ca ITPK and IP

Sections du résumé

Background UNASSIGNED
Inositol 1,3,4,5-tetrakisphosphate (IP
Objectives UNASSIGNED
To better elucidate a function for IP
Methods UNASSIGNED
Human platelets were utilized in whole blood for thrombus formation, in platelet-rich plasma and washed suspensions for aggregation, and for Ca
Results UNASSIGNED
GNF362-enhanced platelet aggregation stimulated by low concentrations of ADP, collagen, thrombin, U46619, and thrombus formation in collagen-coated capillaries. GNF362 induced a transient elevation of Ca
Conclusion UNASSIGNED
ITPK and IP

Identifiants

pubmed: 38404940
doi: 10.1016/j.rpth.2024.102326
pii: S2475-0379(24)00013-X
pmc: PMC10885593
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102326

Informations de copyright

© 2024 The Author(s).

Auteurs

Kalwant S Authi (KS)

School of Cardiovascular and Metabolic Medicine and Sciences, BHF Centre for Research Excellence, London, UK.

Sabeeya Khan (S)

Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, UK.

Jonathan M Gibbins (JM)

Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, UK.

Susan D Brain (SD)

School of Cardiovascular and Metabolic Medicine and Sciences, BHF Centre for Research Excellence, London, UK.

Classifications MeSH